With its strength as a financial centre and access to global funding, London has established itself as one of the most important technological eco-systems in Europe. We have seen the success of Tech City and other tech hubs evolving around London and elsewhere. Funding initiatives, such as the £10bn biotech fund recently proposed by Boris Johnson, also demonstrate the continued appetite for growth in the technology and innovation sector, in particular in life sciences and healthcare. 

We advise leading providers of financial solutions to technology and life sciences companies worldwide.  Our technical expertise and thorough understanding of the most innovative technologies enables us to assist our clients on some of the most challenging and complex finance transactions.  Our advice is always pragmatic and solutions-oriented. When required, we are able to call on the expertise of leading specialists in our internationally based Technology, Outsourcing and Privacy, Intellectual Property and Life Sciences groups who are at the forefront of developments in the market.

We understand the unique characteristics of assets owned and challenges faced by technology and life sciences companies and the entrepreneurial life cycle from start-ups, to venture capital through to growth and acquisition financing, private equity and ultimately exit.  Working closely with our Corporate department we advise our clients, both lenders and borrowers, on the merits of any combination of capital structure in order to achieve the right balance between debt and equity at each stage of the life cycle.


Notable deals / highlights

  • Acting for one of our long-standing clients, a Californian bank, on the provision of customised financial solutions to technology and life science companies across the globe. The transactions we advise on are often multi-jurisdictional and comprise term and working capital loan facilities as well as asset based financing. Over the years, we have advised this bank on numerous deals ranging from US$ 1 million to US$ 50 million.  We have also recently advised on the first two life sciences transactions that this bank has completed in the UK.

  • Advising another long-standing client, an investment firm based in California, on the provision of venture capital funding to late-stage life science and technology companies that need specialty lending solutions. We provide advice on transactions involving working capital lines of credit, term loans and convertible debt loans.

  • Advising one of the operators of crowd funding platforms on an online funding opportunity connecting investors with a B2B digital marketing solutions business. As part of this transaction, we advised on agency arrangements to enable the operator of the online funding platform to act on behalf of and to hold security for the individual investors.

  • Acting for a specialist bank in connection with the provision of senior term loan facilities for the purpose of financing the management buyout of a large group of telecommunication services companies with a particular focus on multi-tenanted buildings.

Expertise spotlight

Key contact Show all

Key contact Show all

Key contact Show all

Expertise activity stream